Geoffrey Ling MD - 31 Aug 2023 Form 4 Insider Report for Celularity Inc (CELU)

Role
Director
Signature
/s/ Kyle Fletcher, Attorney-in-Fact
Issuer symbol
CELU
Transactions as of
31 Aug 2023
Net transactions value
$0
Form type
4
Filing time
16 Oct 2023, 20:06:20 UTC
Previous filing
07 Jan 2022
Next filing
06 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CELU Stock Option Grant (Right to Buy) Award $0 +1,250,000 $0.000000 1,250,000 31 Aug 2023 Class A Common Stock 1,250,000 $0.3240 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted pursuant to the Issuer's 2021 Equity Incentive Plan. The shares underlying such option will vest in three successive equal annual installments measured from the grant date, subject to the Reporting Person's continuous service with the Issuer through each such date.